Jonathan Sims is a Senior Director at Eli Lilly and Company, having held this position since 2022 after serving as a Director. Previously, Sims worked as a Principal Research Scientist, focusing on significant research contributions related to atopic dermatitis and COVID-19. They earned a Ph.D. in Molecular & Biomedical Pharmacology from the University of Kentucky and a B.S. in Recombinant Genetics and Chemistry from Western Kentucky University. Sims' research has been published in several reputable journals, showcasing a commitment to advancing medical science.
This person is not in the org chart
This person is not in any teams
This person is not in any offices